A phase III long-term study of HP-3000 in patients with Parkinson's disease

Trial Profile

A phase III long-term study of HP-3000 in patients with Parkinson's disease

Recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Feb 2015

At a glance

  • Drugs Ropinirole (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Sponsors Hisamitsu Pharmaceutical
  • Most Recent Events

    • 04 Feb 2015 New trial record
    • 16 Dec 2014 Status changed from planning to recruiting, as reported by the Japan Pharmaceutical Information Center: JAPIC Clinical Trials Information record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top